News & Perspective

Aug 09, 2019

Aug 09, 2019

News Scan for Aug 09, 2019

Adjuvanted flu vaccine trial
Polio in Pakistan
Antibiotics and rheumatoid arthritis
Bioweapons detection investigation request

Oct 05, 2017

Oct 05, 2017

Flu Scan for Oct 05, 2017

Research and pandemic readiness
Reusable respirators
Monoclonal antibody partnership

Feb 28, 2017

Feb 28, 2017

News Scan for Feb 28, 2017

Zika study rejected
Asymptomatic Ebola
MERS cases
CEPI names CEO
Biosecurity lab in China

May 02, 2014

May 02, 2014

News Scan for May 02, 2014

More MERS-CoV antibodies
Ebola in Guinea
Renamed biodefense board
Universal flu vaccine

Aug 14, 2013

Aug 14, 2013
H5N1 color electron micro

Study: Technique adds 'kill switch' to modified flu viruses

A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Dec 18, 2012

Dec 18, 2012

Experts at NIH meeting say H5N1 research moratorium may end soon

(CIDRAP News) – As a meeting to discuss issues related to federally funded H5N1 avian influenza research wrapped up today, experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon and said they sensed agreement about lab biosecurity levels.

Nov 19, 2012

Oct 09, 2012

Oct 09, 2012

Experts ponder H5N1 research moratorium issues

(CIDRAP News) – The moratorium on research leading to more-transmissible H5N1 avian influenza viruses, originally set for 60 days, has remained in place for 8 months without a clear end in sight, but a series of commentaries in mBio today from experts familiar with the issues offers some clues for possible next steps.

Jul 31, 2012

Jul 31, 2012

Fauci urges continuing pause on risky H5N1 studies

(CIDRAP News) – The head of the US agency that funds much influenza research today called on scientists to continue their voluntary moratorium on certain kinds of potentially hazardous H5N1 research, saying they need to better address public concerns about the studies, according to news reports from a flu meeting in New York City.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»